Recep Adiyaman
Vision About Experience Education Skills Publications Tools Newsletter Updates Podcasts Blog Contact CV Subscribe
All Issues
Older Newer
Daily Signal March 11, 2026 · 7 min read

Issue #65: Multispectral, Molecular Docking, and Dynamics Simulation Studies of Secalonic Acid F Binding to Human Serum Albumin.

Protein Design Digest - 2026-03-11 - A multimodal approach integrating spectroscopy, deep learning guided molecular docking, and molecular dynamics simulation for predictive assessment of pioglitazone to albumin binding for formulation development.

Share X LinkedIn
Protein Design Daily

Building something in Protein Design?

I love collaborating on new challenges. Let's build together.

LinkedIn Email

Subscribe to Protein Design Digest

Daily curated signals from arXiv, PubMed, and BioRxiv.

Signal of the Day

Multispectral, Molecular Docking, and Dynamics Simulation Studies of Secalonic Acid F Binding to Human Serum Albumin.

Secalonic acid F (SAF) is a fungal secondary metabolite with broad pharmacological activities. This study investigated the interaction mechanism between SAF and HSA through multispectral techniques, molecular docking, and molecular dynamics simulations. The results show that SAF effectively reduces the intrinsic fluorescence of HSA through static quenching and forms a stable 1:1 molar ratio SAF-HSA complex. SAF binds to the second domain site of HSA. The binding reaction is a spontaneous, exothermic process driven by enthalpy, mainly stabilized through hydrogen bonds and van der Waals forces. Spectral analysis confirmed an increase in the α-helical structure of HSA upon binding. Molecular docking and molecular dynamics simulations, including analyses of RMSD, RMSF, and Rg, further supported and elucidated the experimental results.

Why this matters:

Also Worth Reading

Binding interactions of Trametes villosa and Trametes lactinea laccases with 4-nonylphenol and its intermediates: molecular docking and molecular dynamics approaches.

Emerging pollutants such as 4-nonylphenol (4-NP) act as endocrine disruptors and have been associated with reproductive toxicity in humans and wildlife, as well as with physiological disturbances in aquatic, terrestrial, and plant organisms. Laccases are oxidoreductases with notable biotechnological relevance and the ability to oxidize phenolic pollutants, making them attractive candidates for biodegradation strategies. This study investigated the interactions between laccases from Trametes villosa and Trametes lactinea and 4-NP and its degradation intermediates via molecular docking and molecular dynamics simulations (MDS). Ligands were geometrically optimized using the PM7 semiempirical method, and their global reactivity descriptors were computed to explore correlations between electronic properties and laccase binding affinity. Docking revealed favorable binding energies (ΔG bind ≈ -6 kcal·mol -1 ) and recurrent interactions with key amino acid residues, including Ala, Glu, Leu, Phe, Pro, Ser, Val, and His, mainly through hydrogen bonding and hydrophobic contacts. The MDS confirmed the stability of the enzyme-ligand complexes, as indicated by low root mean square deviation (RMSD) and root mean square fluctuation (RMSF) values, along with consistent radius of gyration and solvent-accessible surface areas throughout the trajectories. Binding free energy calculations using the Molecular Mechanics/Poisson-Boltzmann Surface Area (MM/PBSA) method indicated stronger binding affinity under solvation, with ΔG bind values of -26.45 and -17.73 kcal·mol -1 for T. villosa and T. lactinea, respectively, highlighting hydrophobic and van der Waals contributions as the primary stabilizing forces. Overall, these results provide computational evidence that laccases from T. villosa and T. lactinea have potential for application in the oxidative biodegradation of 4-NP. These findings advance the molecular understanding of fungal laccase‒pollutant interactions and support future in vitro validation and protein engineering strategies aimed at enhancing biodegradation efficiency.

Artificial intelligence driven protein design and sustainable nanomedicine for advanced theranostics.

The integration of artificial intelligence, protein engineering, and sustainable nanomedicine is driving a paradigm shift in theranostics by enabling highly precise disease diagnosis and targeted therapy. AI-driven methodologies, including machine learning and deep learning, facilitate the rapid analysis of complex biological and chemical datasets, accelerating protein structure prediction, molecular docking, and structure-activity relationship modeling. These capabilities support the rational design of proteins and peptides with enhanced specificity, therapeutic efficacy, and safety, while enabling personalized treatment strategies tailored to individual molecular profiles. In parallel, sustainable nanomedicine focuses on the development of biodegradable, biocompatible, and environmentally benign nanomaterials to improve drug bioavailability, stability, and controlled release. AI-assisted optimization further refines nanocarrier design by balancing therapeutic performance with safety and environmental impact. Advanced intelligent nanocarriers capable of real-time monitoring, adaptive drug release, and degradation into non-toxic by-products represent a significant advancement over conventional static systems. The theranostic paradigm has become central to precision medicine, particularly in oncology, especially where AI-designed nanoplatforms enable targeted delivery of imaging agents and therapeutics to tumors, while allowing continuous treatment monitoring and minimizing off-target effects. Emerging applications in neurological, infectious, and cardiovascular diseases further highlight the broad clinical potential of this approach. Accordingly, this review summarizes AI-driven protein design strategies, sustainable nanocarrier engineering, and their convergence in next-generation theranostic systems, critically discussing mechanistic insights, translational challenges, and design principles required for developing safe, scalable, and clinically adaptable intelligent nanomedicines.

Establishing FDA-approved oncology drugs as GPR176 inhibitor through homology modelling, molecular docking, MMGBSA, DFT, and molecular dynamics simulation.

Research & AI Updates

From the Industry

Quick Reads

Study on the Potential Molecular Mechanisms of Sodium Dehydroacetate (Na-DHA) Interfering With Bone Metabolism and Inducing Osteoporosis Based on Network Toxicology, Molecular Docking, and In Vitro Experimental Validation.

Sodium Dehydroacetate (Na-DHA), a widely used food additive, has raised concerns about the chronic health risks associated with long-term exposure. Read more →

Multispectral, Molecular Docking, and Dynamics Simulation Studies of Secalonic Acid F Binding to Human Serum Albumin.

Secalonic acid F (SAF) is a fungal secondary metabolite with broad pharmacological activities. Read more →

Utilizing Molecular Docking to Investigate Some Phenolic Acid Phytochemical Interactions with Platelet Aggregation Pathway Proteins.

<b>Background and Objective:</b> Platelet aggregation plays a critical role in hemostasis and thrombosis and its dysregulation can lead to cardiovascular disorders such as stroke and myocardial infarction. Read more →

Design, Synthesis, and Characterization of Novel 1,3,4-Thiadiazole-Benzo[b]Oxepine Derivatives: Study of Their Antiproliferative Activity, Docking, DFT, and ADME-T Properties.

Driven by the urgent need for novel anticancer agents capable of overcoming limitations associated with conventional therapies, a new series of benzo[b]oxepine derivatives featuring 1,3,4-thiadiazole (5a-5k) linkers was successfully produced through a Vilsmeier-Haack reaction, thiazole formation, and C─N cross coupling or an Ullmann-type coupling reaction with the corresponding hydrazides. Read more →

Integrated multi-target pharmacology of ginseng in acute myeloid leukemia through single-cell sequencing, molecular docking, network pharmacology, and in vitro experiments.

Integrated experimental and computational insights into the anti-inflammatory potential of flower-derived exosome-like nanoparticles targeting the NF-κB pathway.

Introduction Dysregulated inflammation underlies numerous chronic pathologies, with the NF-κB p65-p50 heterodimer acting as a pivotal transcriptional regulator that mediates different inflammatory responses. Read more →

Investigating the Structural Basis of Diacetyl Recognition by the G-Protein-Coupled Receptor ODR-10 in <i>Caenorhabditis elegans</i>.

G-protein-coupled receptors (GPCRs) are among the most versatile molecular sensors in biology, capable of sensing and responding to a wide range of molecules and serving as key targets in drug discovery. Read more →

Deciphering the acute toxicity mechanisms of PFAS in algae: A molecular descriptor and binding energy hierarchy perspective.

Per- and polyfluoroalkyl substances (PFASs) are globally persistent pollutants, yet their molecular mechanisms of toxicity in aquatic organisms remain unclear. Read more →

Pipeline Tip

Index your BigWig files before visualization to save memory.

Resources & Tools

The protein structure is the language of life; design is its poetry. — Recep Adiyaman

BS HF DK